Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2021 Jun;51(6):e13532.
doi: 10.1111/eci.13532. Epub 2021 Mar 15.

Cardiac troponin and COVID-19 severity: Results from BIOCOVID study

Luis García de Guadiana-Romualdo  1 Daniel Morell-García  2 Olaia Rodríguez-Fraga  3 Cristian Morales-Indiano  4 Ana María Lourdes Padilla Jiménez  5 José Ignacio Gutiérrez Revilla  6 Eloísa Urrechaga  7 José María Álamo  8 Ana María Hernando Holgado  9 María Del Carmen Lorenzo-Lozano  10 Silvia Sánchez Fdez-Pacheco  11 Patricia de la Hera Cagigal  12 María Ángeles Juncos Tobarra  13 Juan A Vílchez  14 Isabel Vírseda Chamorro 1st  15 Irene Gutiérrez Garcia  16 Yolanda Pastor Murcia  17 Laura Sahuquillo Frías  18 Laura Altimira Queral  19 Elisa Nuez-Zaragoza  20 Juan Adell Ruiz de León  21 Alicia Ruiz Ripa  22 Paloma Salas Gómez-Pablos  23 Iria Cebreiros López  24 Amaia Fernández Uriarte  25 Álex Larruzea  26 María Luisa López Yepes  27 Natalia Sancho-Rodríguez  28 María Consuelo Zamorano Andrés  29 José Pedregosa Díaz  30 Cristina Acevedo Alcaraz  31 Alfonso-L Blázquez Manzanera  32 Sonia Pérez Sanmartín  5 María Del Carmen Baamonde Calzada  6 Marina Vera  8 Elena Valera Nuñez  10 Magdalena Canalda Campás  11 Sara García Muñoz  12 Josep Miquel Bauça  2 Luis Vicente Gutiérrez  13 Laura Jiménez Añón  4 Alfonso Pérez Martínez  14 Aurelio Pons Castillo  15 Ruth González Tamayo  16 Jorge Férriz Vivancos  17 María José Alcaide Martín  3 Vicente Ferrer Díaz de Brito Fernández  33 Vicente Aguadero  20 María Gloria García Arévalo  21 María Arnaldos Carrillo  24 Mercedes González Morales  1 María Núñez Gárate  25 Cristina Ruiz Iruela  26 Patricia Esteban Torrella  28 Martí Vila Pérez  30 Jose Manuel Egea-Caparrós  31 Luis Sáenz  32 Amparo Galán Ortega  34 Luciano Consuegra-Sánchez  35
Affiliations
Observational Study

Cardiac troponin and COVID-19 severity: Results from BIOCOVID study

Luis García de Guadiana-Romualdo et al. Eur J Clin Invest. 2021 Jun.

Abstract

Background: Myocardial injury is a common finding in COVID-19 strongly associated with severity. We analysed the prevalence and prognostic utility of myocardial injury, characterized by elevated cardiac troponin, in a large population of COVID-19 patients, and further evaluated separately the role of troponin T and I.

Methods: This is a multicentre, retrospective observational study enrolling patients with laboratory-confirmed COVID-19 who were hospitalized in 32 Spanish hospitals. Elevated troponin levels were defined as values above the sex-specific 99th percentile upper reference limit, as recommended by international guidelines. Thirty-day mortality was defined as endpoint.

Results: A total of 1280 COVID-19 patients were included in this study, of whom 187 (14.6%) died during the hospitalization. Using a nonspecific sex cut-off, elevated troponin levels were found in 344 patients (26.9%), increasing to 384 (30.0%) when a sex-specific cut-off was used. This prevalence was significantly higher (42.9% vs 21.9%; P < .001) in patients in whom troponin T was measured in comparison with troponin I. Sex-specific elevated troponin levels were significantly associated with 30-day mortality, with adjusted odds ratios (ORs) of 3.00 for total population, 3.20 for cardiac troponin T and 3.69 for cardiac troponin I.

Conclusion: In this multicentre study, myocardial injury was a common finding in COVID-19 patients. Its prevalence increased when a sex-specific cut-off and cardiac troponin T were used. Elevated troponin was an independent predictor of 30-day mortality, irrespective of cardiac troponin assay and cut-offs to detect myocardial injury. Hence, the early measurement of cardiac troponin may be useful for risk stratification in COVID-19.

Keywords: COVID-19; SARS-CoV-2; cardiac troponin I; cardiac troponin T; myocardial injury; prognosis.

PubMed Disclaimer

Conflict of interest statement

The authors declared no potential conflicts of interest with respect to the research, authorship and/or publication of this article.

Figures

FIGURE 1
FIGURE 1
Flow chart of patient recruitment
FIGURE 2
FIGURE 2
Cumulative incidence of 30‐day mortality during hospitalization stratified by baseline cardiac troponin level
FIGURE 3
FIGURE 3
Cumulative incidence of 30‐day mortality during hospitalization stratified by baseline cardiac troponin T level
FIGURE 4
FIGURE 4
Cumulative incidence of 30‐day mortality during hospitalization stratified by baseline cardiac troponin I level

Comment in

References

    1. Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727‐733. - PMC - PubMed
    1. Zhou P, Yang X‐L, Wang X‐G, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270‐273. - PMC - PubMed
    1. Wu F, Zhao SU, Yu B, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579:265‐269. - PMC - PubMed
    1. Madjid M, Safavi‐Naeini P, Solomon SD, Vardeny O. Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiol. 2020;5:831‐840. - PubMed
    1. Centurión OA, Scavenius KE, García LB, Torales JM, Miño LM. Potential mechanisms of cardiac injury and common pathways of inflammation in patients with COVID‐19. Crit Pathw Cardiol. 2021;20:44‐52. - PMC - PubMed

Publication types